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Opioid management
South Africa faces increasing drug dependency problems. 
Much has recently been made of the serious ‘tik’ abuse 
problem among children in the Western Cape. The SAMJ 
has also carried a plea for the abolition from clinical use 
of pethidine in favour of morphine as the former is more 
likely to have harmful effects including addiction, especially 
among medical practitioners. Lize Weich and colleagues 
provide a timely review of the medical management of opioid 
dependence in South Africa.1 
Heroin is the main illicit opioid of abuse, with an increasing 
trend in South Africa. Between 11% and 20% of all patients 
who presented for substance rehabilitation in the second half of 
2006 stated that heroin was their primary or secondary drug of 
choice. The use of heroin in combination with other drugs has 
also become popular. Heroin is mostly smoked in South Africa.
Opioid dependence is a chronic relapsing disease that 
develops from repeated self-administration of opioids, including 
heroin, over-the-counter and prescription opioids. Genetic and 
environmental factors contribute to its development.
The aim of treatment for opioid dependence is total 
abstinence from all opioids, but the short-term success rate is 
low.  Trends in treating opioid dependence have moved from 
focusing only on total opioid abstinence towards including 
strategies aimed at harm reduction (keeping patients alive until 
they eventually go into remission). 
In substitute opioid prescribing, reviews have confirmed that 
maintenance treatment with methadone and buprenorphine 
has proven effectiveness provided that adequate dosages are 
prescribed and appropriate supervision is given.
Nuchal translucency in first-trimester 
screening
The use of first-trimester screening to detect chromosomal 
and structural abnormalities is well established. Health care 
costs have risen above inflation over the last decade, with only 
marginal increments in the health budget, and as a result many 
first-trimester screening centres in Gauteng have been forced to 
omit biochemical screening. 
Naidoo and colleagues from the fetal medicine unit at 
Chris Hani Baragwanath Hospital evaluated the use of a first-
trimester screening programme without biochemical screening, 
in a predominantly black population.2    
Their programme to detect structural and chromosomal 
abnormalities was shown to be cost effective with an efficacy 
equivalent to international standards. This is a positive finding 
for South Africa, where budget limitations influence the 
quality of medical services provided. The benefit of a reduced 
procedure rate in the setting of a high incidence of HIV 
seropositivity lends additional benefit to the implementation of 
a first-trimester screening programme. 
HIV positive results: coping strategies
Experts and other interested parties have pleaded for the 
‘normalisation’ of HIV/AIDS, which would include testing for 
it as for any other disease. Built into the existing programme 
of voluntary testing is supposedly a system of counselling. But 
with the lack of capacity at most public health facilities, what 
will happen if testing is increased and more people receive 
notice of being HIV-positive?   
Tim Myint and Bob Mash investigated the coping strategies 
and social support after receiving HIV-positive results at a 
South African district hospital.3 The initial reaction to extreme 
bad news includes physiological, cognitive and emotional 
responses.
The ability to cope with change is related to the nature of 
the change, availability of social support and personal factors. 
Social support can offer practical help, provide information, or 
help contain or deal with strong emotions. Poorer adjustment 
is associated with persistent denial, venting of emotions, and 
behaviour disengagement that avoids dealing with change. 
How a health care worker breaks the bad news is an additional, 
important factor in a patient’s ability to cope with it.
There was a significant association between social support 
from families and religion as a coping strategy.
Corticosteroids in Pneumocystis 
jiroveci pneumonia in infants
Randomised trials recommend adjunctive corticosteroid 
therapy for P. jiroveci pneumonia (PCP) in adults. Terblanche 
and colleagues investigated the use of adjunctive corticosteroid 
treatment of clinical PCP in infants in a randomised controlled 
trial.4
A study found PCP in 16 - 51% of HIV-positive African 
children who died from respiratory illness, being the most 
common cause of death in HIV-infected infants less than 6 
months of age.
Patients with a clinical diagnosis of PCP were randomised 
to receive either prednisone or placebo. They concluded 
that in HIV-exposed infants with clinical PCP, adjunctive 
corticosteroid therapy does not appear to add benefit 
regarding time to recovery or oxygen independency, but early 
administration may improve survival. A large multicentred 
trial is needed to confirm these findings.
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